This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The enactment of adult-use cannabis legalization laws in Colorado and Washington is associated with increased tourism in both states, according to data published in the Journal of Regional Analysis & Policy. Additional information appears in the NORML fact-sheet , “Marijuana Regulation: Impact on Health, Safety, and Economy.”
Importation, cultivation, production, and other activities conducted for medicinal and scientific purposes are lawful under federal Australian law when the necessary licenses and permits have been obtained. Therapeutic Goods Regulations 1990 State and Territory Laws oversee advertising, distribution, and other local requirements.
The enactment of state-specific medical cannabis access laws is associated with a decline in workers’ compensation claims, according to data published in the journal Health Economics. ” They concluded: “Our findings add to the small, but growing, literature on the effects of MMLs on labor market outcomes.
The National Organization for the Reform of Marijuana Laws wishes to reiterate its message that cannabis consumers and others beware of online misinformation surrounding the use of either whole-plant cannabis or CBD as a potential remedy for the COVID-19 virus. ”
Northam also recommended technical amendments which must be approved by the legislature before the new law takes effect July 1, 2020. The law reduces penalties for offenses involving the possession of up to one ounce of marijuana to a civil violation – punishable by a maximum $25 fine, no arrest, and no criminal record.
A brand new study featured in the journal Drug and Alcohol Dependence delivered exciting news to psychiatrists, health professionals, and law enforcement officials across the United States and beyond. The investigation assessed the suitability of using smartphone sensor data to detect cannabis intoxication, and it had promising results.
The new law takes effect July 1, 2020 and reduces penalties for offenses involving personal possession of up to one ounce of marijuana to a civil violation – punishable by a maximum $25 fine, no arrest, and no criminal record. Become a member Virginia NORML and join the fight to reform marijuana laws in the Commonwealth.
Currently, thousands of state-licensed and regulated businesses lack access to the banking industry and are unable to accept credit cards, deposit revenues, or write checks to meet payroll or pay taxes because federal law discourages financial institutions from engaging in such partnerships.
The enactment of statewide legislation permitting adult cannabis possession and sales is not associated with any significant or long-term uptick in criminal activity, according to data published in the journal Justice Quarterly. Additional information is available from the NORML fact-sheet , ‘Marijuana Regulation and Crime Rates.’
Also introduced was The Marijuana Data Collection Act of 2019 , which would study the effects of state legalized medicinal and non-medicinal marijuana programs from a variety of perspectives, including state revenues, public health, substance abuse and opioids, criminal justice, and employment.
An additional fifteen states have passed laws specific to the possession of cannabidiol (CBD) oil for therapeutic purposes. Sixty-eight percent of registered voters “support the legalization of marijuana,” according to national polling data compiled by the Center for American Progress.
The New York State Association of Police said traffic safety is a major concern, citing an increase in vehicle-related fatalities by 62 percent in Colorado the first year cannabis was legalized in the state. Please visit www.rocnorml.org for more information about how you can get involved and follow ROC NORML on Facebook and Twitter. .
Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. How to Use the Data. Advantages of Data, Macro, and Micro. RYAH Group Inc.
” Specifically, federal and state data finds that teen cannabis use has declined in past years – during the same time that many states have legalized and regulated the use of cannabis by adults. ” For more information on the public health and safety of cannabis, please see NORML’s fact-sheets here.
According to research by real estate data company, Clever , property values rose by $17,113 more in states where recreational cannabis is legal, compared to states where it’s illegal or just legal at the medicinal level. Clever combined data from Zillow, the U.S. Administrative costs of initiating new laws. General funds.
Thousands of state-licensed and regulated businesses lack access to the banking industry and are unable to accept credit cards, deposit revenues, or write checks to meet payroll or pay taxes because federal law discourages financial institutions from engaging in such partnerships.
– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. The poster presentation of the data was by Dr. Scott Tagawa , a Professor of Medicine & Urology at Weill Cornell Medicine and an AIkido Pharma Scientific Advisory Board member. – Phase 2 Trial Underway. Forward-Looking Statements.
Over 650,000 Americans, disproportionately black, brown, young, and poor, are arrested for violating marijuana laws annually. ” “For far too long, the impact of America’s repressive, archaic marijuana laws has been felt most heavily by people of color,” said Representative Hakeem Jeffries (NY-08).
Law Enforcement Related to Cannabis. Public Safety (PS) is supporting efforts to enforce the legalization and regulation of cannabis through activities to deter criminal activity and to help ensure that organized crime does not penetrate the legalized system. Background. Current Status.
Earlier this month, the FDA released a seven-page plan to accelerate its research into the safety of cannabis-derived products. Piloting market surveillance tools to monitor unapproved cannabis-derived products and “identify potential safety issues before the issues become mainstream.”
The North American College of Pharmaceutical Technology (NACPT) is conducting a pilot series of professionals in medical cannabis workshops, and we spent a day learning and discussing food safety, regulatory tech, processes and systems. Is the temperature and humidity control right for product safety? Source: [link].
These arrests do not promote public safety, cost taxpayers millions of dollars, and disproportionately impact the poor and communities of color. It is pivotal that leadership continues to move forward to address and enact needed marijuana law reforms in New Jersey, including efforts to expunge past low-level marijuana convictions.”
This Act amends the Controlled Substances Act to reduce the number of instances in which federal law enforcement agencies could carry out legal actions against state-licensed cannabis businesses or other related enterprises. “The majority of states now regulate either the medical use or the adult use of marijuana. .”
According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 The history of the law surrounding this subject may offer insight. Therefore, the law prohibited the utilization of even medical marijuana.
Last Thursday, a collation of twenty-six House members sent a letter to the FDA, urging the agency to develop a path for the lawful marketing of Hemp-CBD products. The spending reports mandates the FDA to clear a path for the lawful marketing of these products within 120 days. House of Representatives.
On January 16, the House Criminal Justice and Public Safety Committee heard testimony for and against HB 481 during a public hearing. Statewide polling data shows that 68 percent of New Hampshire adults support “legalizing [the] possession of small amounts of marijuana for personal recreational use.”
New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.
“This partnership with WSU and Qwibil will help us research the safety and efficacy of cannabis as medicine for our patients’ use.”. McDonell said research institutions are limited in their access to cannabis users by federal laws that could affect funding. They’re in a unique space,” McDonell said of the Puyallup tribe.
Law enforcement, policy makers, and public citizens have long debated how recreational marijuana legalization influences crime and public safety. Data tells us that more arrests for marijuana trafficking and possession occur after marijuana legalization in neighboring states, concentrated at the bordering counties.
Despite its multi-year process of assessing potential exceptions from the Drug Preclusion and evaluating the safety and science of CBD, the FDA has not changed its prohibitive approach. However, the plain language of the Drug Preclusion, supporting case law ( see Pharmanex, Inc. SafetyData Matters. Shalala , 35 F.
In addition to the letters, the FDA published a revised Consumer Update detailing safety concerns about CBD products more broadly. As FDA Principal Deputy Commissioner Amy Abernathy remarked, the FDA will “take action as needed against companies that violate the law in ways that raise a variety of public health concerns.”
This bill mandated that the Division of Criminal Justice in the Department of Public Safety conduct a study of the impacts of Amendment 64, particularly as these relate to law enforcement activities. Furthermore, the measurement of available data elements can be affected by very context of marijuana legalization. 13-283 (C.R.S.
Specifically, the FSA is giving the CBD industry until March 31, 2021 to submit valid novel food authorization applications to ensure these products meet specific safety standards. Following the March 31, 2021 deadline, only products for which a valid application has been submitted will be allowed to remain on the market.
Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. Jenn Michelle Pedini: Virginia passed one of the nation’s first medical marijuana laws way back in 1979. The 2015 Virginia law is an affirmative defense law.
As the psychedelic renaissance contributes to a swelling pool of safety and efficacy data pertaining to the potential therapeutic benefits of psychedelic medicine, many localities—particularly in North America—are revising their legal frameworks. The map below seeks to track these initiatives.
2019 is shaping up to be the most significant year in the marijuana reform movement to date and it’s a testament to one thing: That people just like you are getting involved and changing laws. This is not by accident. The power that we have built over the last 49 years is cresting and the end of prohibition is finally in sight.
The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.
This bill mandated that the Division of Criminal Justice in the Department of Public Safety conduct a study of the impacts of Amendment 64, particularly as these relate to law enforcement activities. Furthermore, the measurement of available data elements can be affected by very context of marijuana legalization. 13-283 (C.R.S.
are increasingly relaxing their cannabis laws, it’s no surprise that the drug’s consumption has grown , especially among American workers. Quest Diagnostics started analyzing yearly workplace drug testing data 25 years ago in 1988, and the result of their recent study was published on May 18. As many states across the U.S.
Hoban Law Group is delighted to announce that Managing Attorney Garrett Graff was selected by the U.S. at the Scientific Data and Information about Products Containing Cannabis or Cannabis-Derived Compounds Public Hearing on Friday, May 31, 2019. FDA Products Containing Cannabis or Cannabis-Derived Compounds Public Hearing.
Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Their participation strengthened the statistical reliability of both the liver safety results and achieved statistical relevance for both sleep and testosterone results.
NEW STUDY DEMONSTRATES CBD’S STRONG SAFETY PROFILE , AMPLIFIES CALLS FOR FDA REGULATION. Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. The second cohort included an additional 222 individuals taking CBD produced by an additional five companies.
For the past six months, the federal agency has been bombarded with messages, urging the FDA to promptly develop a regulatory pathway for the lawful use of hemp-derived CBD (“Hemp-CBD”) in foods and dietary supplements. The Food and Drug Administration (“FDA”) seems to be listening.
FDA’s actions send a discouraging message to the entire hemp and CBD industry, especially in light of the fact that these firms provided more than ample safetydata and cooperated with FDA’s requests throughout the process.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content